| 4980 |
Dexerials Corporation
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary [IFRS] (Consolidated)
|
Feb 9, 2026
|
| 4613 |
Kansai Paint Co., Ltd.
|
Earnings |
|
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
|
Feb 9, 2026
|
| 4523 |
Eisai Co., Ltd.
|
Earnings |
|
Fiscal Year 2025 Q3 Financial Results Briefing
|
Feb 9, 2026
|
| 4523 |
Eisai Co., Ltd.
|
Personnel |
|
Notice Regarding New Executive Officer Structure
|
Feb 9, 2026
|
| 4523 |
Eisai Co., Ltd.
|
Earnings |
|
FY2025 Q3 Financial Results
|
Feb 9, 2026
|
| 4523 |
Eisai Co., Ltd.
|
Earnings |
|
Financial Summary for the Third Quarter of Fiscal Year Ending March 2026 [IFRS] (Consolidated)
|
Feb 9, 2026
|
| 4516 |
Nippon Shinyaku Co., Ltd.
|
Earnings |
|
FY2026 Q3 Financial Summary〔IFRS〕(Consolidated)
|
Feb 9, 2026
|
| 4385 |
Mercari, Inc.
|
Earnings |
|
Notice Regarding Revision of Full-Year Consolidated Earnings Guidance
|
Feb 9, 2026
|
| 4385 |
Mercari, Inc.
|
Earnings |
|
Presentation Material FY2026.6 2Q
|
Feb 9, 2026
|
| 4385 |
Mercari, Inc.
|
Earnings |
|
Consolidated Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending June 2026 [IFRS]
|
Feb 9, 2026
|
| 4151 |
Kyowa Kirin Co., Ltd.
|
Dividend |
|
Notice Regarding Change in Dividend Policy (DOE and Progressive Dividend)
|
Feb 9, 2026
|
| 4151 |
Kyowa Kirin Co., Ltd.
|
Earnings |
|
Financial Summary Supplemental Material – Fiscal Year Ending December 2025 –
|
Feb 9, 2026
|
| 4151 |
Kyowa Kirin Co., Ltd.
|
Earnings |
|
Financial Summary for the Fiscal Year Ending December 2025 [IFRS] (Consolidated)
|
Feb 9, 2026
|
| 4063 |
Shin-Etsu Chemical Co., Ltd.
|
Share Buyback |
|
Notice on the Status of Treasury Stock Acquisition (Acquisition of Treasury Stock Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)
|
Feb 9, 2026
|
| 4023 |
Kureha Corporation
|
Earnings |
|
Financial Summary for Q3 FY2026 [IFRS] (Consolidated)
|
Feb 9, 2026
|
| 4021 |
Nissan Chemical Corporation
|
Earnings |
|
FY2026 March Q3 Financial Results Briefing
|
Feb 9, 2026
|
| 4021 |
Nissan Chemical Corporation
|
Earnings |
|
Consolidated Financial Summary for the Third Quarter of Fiscal Year Ending March 2026 [Japanese GAAP]
|
Feb 9, 2026
|
| 3902 |
Medical Data Vision Co., Ltd.
|
Earnings |
|
Fiscal Year Ending December 2025 Financial Presentation Materials
|
Feb 9, 2026
|
| 3902 |
Medical Data Vision Co., Ltd.
|
Earnings |
|
Financial Summary for the Fiscal Year Ending December 2025 [Japan GAAP] (Consolidated)
|
Feb 9, 2026
|
| 3902 |
Medical Data Vision Co., Ltd.
|
Earnings |
|
Notice Regarding Recording of Extraordinary Loss (Impairment Loss on Investment Securities)
|
Feb 9, 2026
|
